4//SEC Filing
Trias Joaquim 4
Accession 0001209191-10-015098
CIK 0001316175other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:07 PM ET
Size
7.2 KB
Accession
0001209191-10-015098
Insider Transaction Report
Form 4
Trias Joaquim
SR VP, Preclinical Development
Transactions
- Conversion
Common Stock
2010-03-04+17,523→ 174,166 total - Conversion
Series A-1 Convertible Preferred Stock
2010-03-04−17,523→ 0 total→ Common Stock (17,523 underlying)
Footnotes (2)
- [F1]Each share of Series A-1 Convertible Preferred Stock was automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The Series A-1 Convertible Preferred Stock has no expiration date.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001483998
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:07 PM ET
- Size
- 7.2 KB